Skip to main content

Research Repository

Advanced Search

All Outputs (5)

Provision of NICE-recommended varicose vein treatment in the NHS (2022)
Journal Article
Hitchman, L., Mohamed, A., Smith, G. E., Pymer, S., Chetter, I. C., Forsyth, J., & Carradice, D. (2023). Provision of NICE-recommended varicose vein treatment in the NHS. British journal of surgery, 110(2), 225-232. https://doi.org/10.1093/bjs/znac392

BACKGROUND: Standardization of access to treatment and compliance with clinical guidelines are important to ensure the delivery of high-quality care to people with varicose veins. In the National Health Service (NHS) in England, commissioning of care... Read More about Provision of NICE-recommended varicose vein treatment in the NHS.

Effects of exercise prescribed at different levels of claudication pain on walking performance in patients with intermittent claudication: a protocol for a randomised controlled trial (2022)
Journal Article
Birkett, S., Sinclair, J., Seed, S., Pymer, S., Caldow, E., Ingle, L., …Egun, A. (2022). Effects of exercise prescribed at different levels of claudication pain on walking performance in patients with intermittent claudication: a protocol for a randomised controlled trial. Therapeutic Advances in Cardiovascular Disease, 16, https://doi.org/10.1177/17539447221108817

Background: Peripheral artery disease affects over 236 million people globally and the classic symptom is intermittent claudication (IC) which is associated with reduction in physical activity. The evidence that supervised exercise programmes (SEPs)... Read More about Effects of exercise prescribed at different levels of claudication pain on walking performance in patients with intermittent claudication: a protocol for a randomised controlled trial.

The Edinburgh Claudication Questionnaire has poor diagnostic accuracy in people with intermittent claudication (2022)
Journal Article
Ibeggazene, S., Cai, P. L., Smith, G. E., Ibbegazene, S., Stirrup, A., Pymer, S., …Chetter, I. C. (in press). The Edinburgh Claudication Questionnaire has poor diagnostic accuracy in people with intermittent claudication. Vascular, https://doi.org/10.1177/17085381211059665

Background: The screening and diagnosis of intermittent claudication is a challenging process and often relies on the expertise of specialist vascular clinicians. We sought to investigate the diagnostic performance of the Edinburgh Claudication Quest... Read More about The Edinburgh Claudication Questionnaire has poor diagnostic accuracy in people with intermittent claudication.

A systematic review of exercise intervention reporting quality and dose in studies of intermittent claudication (2022)
Journal Article
Ibeggazene, S., Pymer, S., Birkett, S. T., Caldow, E., & Harwood, A. E. (in press). A systematic review of exercise intervention reporting quality and dose in studies of intermittent claudication. Vascular, https://doi.org/10.1177/17085381211070700

Background: Exercise therapy is an important treatment option for people with intermittent claudication (IC). Appropriate reporting of exercise interventions in populations with IC within randomised controlled trials (RCTs) is important to ensure tha... Read More about A systematic review of exercise intervention reporting quality and dose in studies of intermittent claudication.

Research priorities for patients with peripheral arterial disease: A James Lind Alliance Priority Setting Partnership (2022)
Journal Article
Pymer, S., Harwood, A., Long, J., Chetter, I., Saratzis, A., & Coughlin, P. (2022). Research priorities for patients with peripheral arterial disease: A James Lind Alliance Priority Setting Partnership. Journal of Vascular Societies Great Britain and Ireland, 1(2), 23-29. https://doi.org/10.54522/jvsgbi.2022.011

Introduction: Peripheral arterial disease (PAD) is a common health problem associated with reduced mobility, functional capacity and quality of life. Significant research exists in the field of vascular surgery, but its relevance to the research prio... Read More about Research priorities for patients with peripheral arterial disease: A James Lind Alliance Priority Setting Partnership.